Closely Watched Mirati Reveals Results to Rival Amgen Drug

Mirati Therapeutics Inc., one of the most talked-about names in biotech and a frequenter of Wall Street’s M&A shopping lists, released drug-trial results that set a higher bar against a competitor drug from biotech behemoth Amgen Inc.